What is the initial management of a patient with DKA or HHS in the ICU?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial ICU Management of DKA and HHS

Begin aggressive fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 mL/kg/h (1-1.5 L in the first hour) to restore intravascular volume and renal perfusion, followed by continuous IV insulin infusion at 0.1 units/kg/h after confirming potassium >3.3 mEq/L, with close monitoring of electrolytes every 2-4 hours. 1, 2

Pathophysiology

DKA Pathophysiology

  • Absolute insulin deficiency leads to uncontrolled lipolysis and ketone body production (β-hydroxybutyrate, acetoacetate, acetone), causing metabolic acidosis with pH <7.3 and bicarbonate <15 mEq/L 3, 4
  • Hyperglycemia (>250 mg/dL) results from decreased glucose utilization and increased hepatic gluconeogenesis 3
  • Osmotic diuresis causes total body water deficit of approximately 6 liters (100 mL/kg) 3

HHS Pathophysiology

  • Relative insulin deficiency with enough insulin to prevent ketosis but insufficient to prevent severe hyperglycemia (>600 mg/dL) 2, 3
  • Profound dehydration with total body water deficit of 9 liters (100-200 mL/kg) due to prolonged osmotic diuresis 3
  • Effective serum osmolality >320 mOsm/kg causes altered mental status and severe dehydration 2, 5
  • Minimal ketosis distinguishes HHS from DKA (pH >7.3, bicarbonate >15 mEq/L) 3, 5

Initial Assessment and Diagnosis

Immediate Laboratory Workup

  • Obtain arterial blood gases, complete blood count with differential, urinalysis, plasma glucose, BUN, electrolytes, chemistry profile, and creatinine immediately 1, 2
  • Order electrocardiogram, chest X-ray, and cultures as clinically indicated to identify precipitating causes 1
  • Calculate effective serum osmolality: 2[measured Na (mEq/L)] + glucose (mg/dL)/18 1, 2
  • Correct serum sodium for hyperglycemia: add 1.6 mEq to sodium value for each 100 mg/dL glucose above 100 mg/dL 1, 2

Diagnostic Criteria

DKA: Blood glucose >250 mg/dL, arterial pH <7.3, bicarbonate <15 mEq/L, moderate ketonuria or ketonemia 1, 3

HHS: Blood glucose >600 mg/dL, arterial pH >7.3, bicarbonate >15 mEq/L, effective serum osmolality >320 mOsm/kg, altered mental status or severe dehydration 2, 3, 5

Fluid Resuscitation Protocol

First Hour

  • Administer isotonic saline (0.9% NaCl) at 15-20 mL/kg/h (typically 1-1.5 L in average adult) to expand intravascular volume and restore renal perfusion 1, 2
  • This aggressive initial resuscitation is critical for both conditions, though HHS requires more total fluid replacement due to greater dehydration 3

After Initial Resuscitation

  • Switch to 0.45% NaCl if corrected serum sodium is normal or elevated after hemodynamic stabilization 1, 2
  • Continue 0.9% NaCl if corrected serum sodium is low 1
  • Target fluid replacement to correct estimated deficits within 24 hours 2, 5

Critical Safety Parameters

  • Limit induced change in serum osmolality to <3 mOsm/kg/h to prevent cerebral edema 2
  • Monitor fluid input/output, hemodynamic parameters, and mental status frequently during resuscitation 1, 2
  • Exercise particular caution in elderly patients and those with cardiac or renal compromise 5

Glucose-Specific Fluid Adjustments

  • When glucose reaches 250 mg/dL in DKA or 300 mg/dL in HHS, change to 5% dextrose with 0.45-0.75% NaCl 1, 2, 5
  • Continue dextrose-containing fluids to prevent hypoglycemia while maintaining insulin therapy to resolve metabolic abnormalities 2, 5

Insulin Therapy Protocol

Pre-Insulin Requirements

  • Do NOT start insulin if potassium <3.3 mEq/L - correct hypokalemia first to prevent life-threatening cardiac arrhythmias 1
  • Ensure adequate fluid resuscitation has begun 6

Adult Insulin Dosing

  • IV bolus: 0.15 units/kg body weight of regular insulin 1
  • Continuous infusion: 0.1 units/kg/h (typically 5-7 units/h in adults) 1
  • Target glucose decline of 50-75 mg/dL per hour 1

Insulin Adjustment Algorithm

  • If glucose does not fall by 50 mg/dL in the first hour: verify adequate hydration, then double insulin infusion rate hourly until achieving steady glucose decline of 50-75 mg/h 1
  • When glucose reaches 250 mg/dL in DKA: decrease insulin to 0.05-0.1 units/kg/h and add dextrose to IV fluids 1
  • When glucose reaches 300 mg/dL in HHS: decrease insulin to 0.05-0.1 units/kg/h (3-6 units/h) 2, 5

Key Insulin Management Principles

  • Continue insulin until resolution of ketoacidosis in DKA (pH >7.3, bicarbonate ≥18 mEq/L, anion gap ≤12 mEq/L), even if glucose normalizes 3
  • In HHS, continue insulin until mental obtundation and hyperosmolarity resolve 2
  • Ketonemia takes longer to clear than hyperglycemia - do not prematurely stop insulin based on glucose alone 1

Electrolyte Management

Potassium Replacement

  • Once renal function confirmed and K+ known, add 20-40 mEq/L potassium to IV fluids 1, 2
  • Use 2/3 KCl or potassium acetate and 1/3 KPO₄ 1, 2
  • Target serum potassium between 4-5 mEq/L 3
  • Potassium deficits are greater in HHS (5-15 mEq/kg) compared to DKA (3-5 mEq/kg) 3

Monitoring Schedule

  • Check electrolytes every 2-4 hours during initial treatment 1, 2
  • Monitor sodium, potassium, chloride, bicarbonate, phosphate, magnesium, glucose, BUN, creatinine, and osmolality 2, 5
  • Venous pH monitoring is adequate for DKA (usually 0.03 units lower than arterial pH) - repeat arterial blood gases are generally unnecessary 1

Other Electrolytes

  • Monitor and correct magnesium and phosphate abnormalities as needed 2
  • Routine phosphate replacement is not recommended unless severe hypophosphatemia develops 1

Ketone Monitoring (DKA-Specific)

  • β-hydroxybutyrate measurement is the preferred method for monitoring DKA resolution 1
  • Avoid nitroprusside method (urine ketones) as it only measures acetoacetate and acetone, not β-hydroxybutyrate 1
  • During therapy, β-hydroxybutyrate converts to acetoacetate, which may falsely suggest worsening ketosis by nitroprusside testing 1

Resolution Criteria and Transition

DKA Resolution

  • Glucose <200 mg/dL 3
  • Serum bicarbonate ≥18 mEq/L 3
  • Venous pH >7.3 3
  • Anion gap ≤12 mEq/L 3

HHS Resolution

  • Osmolality normalized 5
  • Mental status improved 5
  • Hemodynamic stability achieved 5

Transition to Subcutaneous Insulin

  • Administer basal insulin 2-4 hours BEFORE stopping IV insulin to prevent rebound hyperglycemia 2, 3, 5
  • This overlap period is critical - premature termination of IV insulin is a common pitfall 7
  • Consider low-dose basal insulin analog given with IV insulin to prevent rebound hyperglycemia 3

Critical Complications to Monitor

Cerebral Edema

  • Most common in children but can occur in adults with rapid osmolality correction 1, 2
  • Prevent by limiting osmolality change to <3 mOsm/kg/h 2
  • Avoid excessive fluid administration and overly rapid glucose correction 6
  • Monitor mental status continuously for early detection 1, 2

Fluid Overload

  • Particularly dangerous in patients with cardiac or renal compromise 1, 5
  • Monitor hemodynamic parameters, lung sounds, and oxygen saturation closely 1

Hypokalemia

  • Insulin therapy drives potassium intracellularly, potentially causing life-threatening hypokalemia 1
  • Never start insulin if K+ <3.3 mEq/L 1

Bicarbonate Therapy

  • Bicarbonate is NOT routinely recommended as it has not been shown to improve outcomes 3, 5
  • Consider only if pH <6.9 or when pH <7.2 with serum bicarbonate <10 mEq/L pre/post-intubation to prevent hemodynamic collapse 6
  • Bicarbonate can worsen ketosis, cause hypokalemia, and increase cerebral edema risk 6

Precipitating Factors to Address

  • Identify and treat underlying causes: infection (most common), myocardial infarction, stroke, medications (diuretics, corticosteroids, beta-blockers), non-adherence to insulin 2, 5, 4
  • The antibiotic choice (piperacillin-tazobactam 4.5g) mentioned in your case is appropriate for suspected infection as a precipitant 1

ICU Admission Criteria

  • Cardiovascular instability 4
  • Inability to protect airway 4
  • Obtundation or altered mental status 4
  • Acute abdominal signs suggesting gastric dilatation 4
  • Need for frequent monitoring and IV insulin infusion 4

Common Pitfalls to Avoid

  • Premature termination of IV insulin before complete resolution of ketoacidosis in DKA 7
  • Insufficient overlap between IV and subcutaneous insulin, causing rebound hyperglycemia 7
  • Starting insulin before correcting hypokalemia (K+ <3.3 mEq/L) 1
  • Overly rapid correction of osmolality (>3 mOsm/kg/h), risking cerebral edema 2
  • Using nitroprusside method to monitor ketone resolution in DKA 1
  • Inadequate fluid resuscitation, particularly in HHS where deficits are greater 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Diabetic Non-Ketotic Hyperosmolar Coma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Approaches for Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperosmolar Hyperglycaemic Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.